Yale Brown Obsessive Compulsive Scale - Pharma

Relevant Publications

Characteristics of Patients With Intractable Obsessive-Compulsive Disorder With High/Low Responsiveness to Gamma Knife Surgery.

Issue Release: 2024

Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder.

Issue Release: 2024

Evaluation of serum zonulin and occludin levels in obsessive-compulsive disorder and the effect of major depressive disorder comorbidity.

Issue Release: 2024

Treating refractory obsessive compulsive disorder with cathodal transcranial direct current stimulation over the supplementary motor area: a large multisite randomized sham-controlled double-blind study.

Issue Release: 2024

The Clinical Efficacy of Accelerated Deep Repetitive Transcranial Magnetic Stimulation in Depression and Obsessive-Compulsive Disorder: Multi-centric Real-World Observational Data.

Issue Release: 2024

The importance of examining early maladaptive schemas in the diagnosis and treatment of obsessive-compulsive disorder.

Issue Release: 2024

Exploring the psychometric properties of the premonitory urge for tics scale (PUTS) and its association with psychiatric symptoms in Chinese children with tic disorders.

Issue Release: 2024

The relationship between parental obsessive-compulsive disorder and children\'s cognitive disengagement syndrome (Sluggish Cognitive Tempo).

Issue Release: 2024

Reliability and validity of a newly developed PANDAS/PANS questionnaire.

Issue Release: 2024

A study of clinical correlates and predictors of insight in obsessive compulsive disorder.

Issue Release: 2024

Repetitive transcranial magnetic stimulation for major depression and obsessive-compulsive disorders in Singapore.

Issue Release: 2024

Long-term safety and efficacy of focused ultrasound capsulotomy for obsessive-compulsive disorder and major depressive disorder.

Issue Release: 2024

Impact of MAOA Gene Polymorphism on the Efficacy of Antidepressant Treatment and Craving Severity for Betel Quid Use Disorder.

Issue Release: 2024

Genetic polymorphism in HTR2A rs6313 is associated with internet addiction disorder.

Issue Release: 2024

Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials.

Issue Release: 2024

Pallidum volume as a predictor for the effectiveness of mindfulness-based cognitive therapy and psycho-education in unmedicated patients with obsessive-compulsive disorder.

Issue Release: 2024

Silent Infections are not So Silent: The Emerging Role of Combined Infections, Inflammation, and Vitamin Levels in OCD.

Issue Release: 2024

Effectiveness of online group cognitive-behavior therapy for adolescents with obsessive-compulsive disorder: a pilot study.

Issue Release: 2024

The Relationship between Childhood Trauma Experiences and Psychotic Vulnerability in Obsessive Compulsive Disorder: An Italian Cross-Sectional Study.

Issue Release: 2024

Exploring latent clusters in pediatric OCD based on symptoms, severity, age, gender, and comorbidity.

Issue Release: 2024

How Can Pharma Companies Improve Patient Education?

What are the Challenges Faced by Generic Manufacturers?

Why do Pharma Companies Use CROs?

What are the Key Cellular Stress Pathways?

What Role Does Technology Play?

What are the Key Challenges?

Why Are Clinical Trials Important?

What Challenges Do Pharmacists Face?

What is the Future of the Pharmacy Profession?

Why is Medication Management Important?

Yale Brown Obsessive Compulsive Scale - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics